72 related articles for article (PubMed ID: 12541829)
1. [Detection of bate 2-microglobulin fibronection and interleukin 2 content in patients with nasopharyngeal carcinoma].
Lin Q; Fu F; Zhang G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Nov; 15(11):499-500. PubMed ID: 12541829
[TBL] [Abstract][Full Text] [Related]
2. [Serum beta 2-microglobulin determination in nasopharyngeal carcinoma patients. An analysis of 139 cases].
Luo ZM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(4):239-40, 256. PubMed ID: 1298313
[TBL] [Abstract][Full Text] [Related]
3. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
[TBL] [Abstract][Full Text] [Related]
4. [The study of vascular endothelial growth factor in nasopharyngeal carcinoma patients before and after radiotherapy].
Liang Y; Cheng Yf; Liu H; Hu L
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Sep; 16(9):474, 476. PubMed ID: 15515536
[TBL] [Abstract][Full Text] [Related]
5. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
[TBL] [Abstract][Full Text] [Related]
6. [Measurement of serum neopterin levels in patients with nasopharyngeal carcinoma and its significance].
Wang L; Jin S; Wei Q; Xiang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 May; 15(5):204-5. PubMed ID: 12541762
[TBL] [Abstract][Full Text] [Related]
7. Serum beta-2-microglobulin in African Burkitt tumour, nasopharyngeal carcinoma and controls.
Cooper EH; Kerruish SM; Gunvèn P
Biomedicine; 1981 Jul; 35(3):104-7. PubMed ID: 6168307
[TBL] [Abstract][Full Text] [Related]
8. [Significance of serum vascular endothelial growth factor test before radiotherapy in patients with nasopharyngeal carcinoma].
Zhao GQ; Xu Y; Wang Q
Zhong Xi Yi Jie He Xue Bao; 2005 Jul; 3(4):274-7. PubMed ID: 16009104
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of elevated serum sICAM-1 in patients with nasopharyngeal carcinoma].
Wang L; Shu M; Wei Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Dec; 35(6):469-71. PubMed ID: 12768764
[TBL] [Abstract][Full Text] [Related]
10. [Serum angiogenin concentration in nasopharyngeal carcinoma patients and its clinical significance].
Xia B; Yang T; Xian J; Wang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):647-8, 651. PubMed ID: 17017190
[TBL] [Abstract][Full Text] [Related]
11. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma.
Yadav M
Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):123-6. PubMed ID: 1948253
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of beta 2-microglobulin content in nasopharyngeal secretion].
Cui D; Su M; Jie Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Jun; 32(3):148-50. PubMed ID: 10743152
[TBL] [Abstract][Full Text] [Related]
13. The elevated serum interleukin-6 correlates with the increased serum butyrate level in patients with nasopharyngeal carcinoma.
Chow KC; Chiou SH; Ho SP; Tsai MH; Chen CL; Wang LS; Chi KH
Oncol Rep; 2003; 10(4):813-9. PubMed ID: 12792728
[TBL] [Abstract][Full Text] [Related]
14. A clinical trial of active immunotherapy with anti-idiotypic vaccine in nasopharyngeal carcinoma patients.
Li G; Xie L; Zhou G; Fu H; Zhou J; Sun Q
Chin Med J (Engl); 2002 Apr; 115(4):567-70. PubMed ID: 12133300
[TBL] [Abstract][Full Text] [Related]
15. Plasma osteopontin, hypoxia, and response to radiotherapy in nasopharyngeal cancer.
Hui EP; Sung FL; Yu BK; Wong CS; Ma BB; Lin X; Chan A; Wong WL; Chan AT
Clin Cancer Res; 2008 Nov; 14(21):7080-7. PubMed ID: 18981006
[TBL] [Abstract][Full Text] [Related]
16. Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
Shiu W; Leung SF; Leung WT; Ho S; Tao M
Br J Cancer; 1992 Sep; 66(3):555-7. PubMed ID: 1520593
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of combined detection of CYFRA21-1 and TSGF in nasopharyngeal carcinoma].
Huang L; Huang W; Chen Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Mar; 19(5):201-2. PubMed ID: 15934283
[TBL] [Abstract][Full Text] [Related]
18. [Significance of detection of serum sialic acid and Epstein-Barr virus VCA-IgA in diagnosis and monitoring radiotherapy effectiveness in nasopharyngeal carcinoma patients].
Jiang LN; Dai LC; He JF; Chen YW; Ma ZH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):30-2. PubMed ID: 16816858
[TBL] [Abstract][Full Text] [Related]
19. [Seric soluble interleukin-2 receptor alpha in nasopharyngeal carcinoma in Tunisia. Prospective study about 45 cases].
Jmal A; Ghanem A; Boussen H; Gara Y; Abaza H; Gara S; Harzallah L; Ladgham A; Guemira F
Tunis Med; 2007 Aug; 85(8):651-4. PubMed ID: 18254285
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
